Novavax, Inc. (NVAX)

Novavax Market Cap

Novavax has a market cap or net worth of $586.40 million as of April 24, 2024. Its market cap has decreased by -28.07% in one year.

• Market Cap: 586.40M
• Enterprise Value: 236.56M
• 1-Year Change: -28.07%
• Ranking: #2818
• Category: Small-Cap
• Stock Price: $4.19

Market Cap Chart

Since December 1, 1998, Novavax's market cap has increased from $25.70M to $586.40M, an increase of 2,181.72%. That is a compound annual growth rate of 13.10%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	586.40M	2.95%
Apr 22, 2024	569.60M	2.52%
Apr 19, 2024	555.60M	2.06%
Apr 18, 2024	544.40M	-
Apr 17, 2024	544.40M	-2.51%
Apr 16, 2024	558.40M	-3.16%
Apr 15, 2024	576.60M	-3.74%
Apr 12, 2024	599.00M	-0.47%
Apr 11, 2024	601.80M	0.94%
Apr 10, 2024	596.20M	-3.62%
Apr 9, 2024	618.60M	-0.23%
Apr 8, 2024	620.00M	0.23%
Apr 5, 2024	618.60M	-0.45%
Apr 4, 2024	621.40M	-2.20%
Apr 3, 2024	635.40M	0.22%
Apr 2, 2024	634.00M	-2.58%
Apr 1, 2024	650.80M	-2.72%
Mar 28, 2024	669.00M	-1.44%
Mar 27, 2024	678.80M	2.97%
Mar 26, 2024	659.20M	-2.08%
Mar 25, 2024	673.20M	2.34%
Mar 22, 2024	657.80M	-0.42%
Mar 21, 2024	660.60M	-2.28%
Mar 20, 2024	676.00M	-2.23%
Mar 19, 2024	691.40M	-3.89%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
GH Research	573.87M
Mesoblast	570.06M
Nuvation Bio	566.92M
Lyell Immunopharma	566.63M
Mineralys Therapeutics	560.34M
Olema Pharmaceuticals	555.23M
OmniAb	546.98M
CureVac	546.27M